Skip to main content

Table 2 Association between vulvovaginal yeast infections during pregnancy, gestational weight gain, oral glucose tolerance test results and gestational diabetes mellitus among 3,931 women

From: Vulvovaginal yeast infections, gestational diabetes and pregnancy outcome

 

Total N (%) or mean (SD)

No infections

One or two infections

Recurrent infections

p-value

Maternal weight gain during pregnancy, kg

13.8 (5.2)

13.8 (5.2)

13.4 (5.0)

14.3 (6.0)

0.378

 ≤ 10

870 (22.1)

771 (21.9)

82 (25.9)

17 (17.9)

0.086

 11–13

854 (21.7)

772 (22.0)

65 (20.6)

17 (17.9)

 

 14–16

824 (21.0)

742 (21.0)

62 (19.6)

20 (21.1)

 

 > 16

1,012 (25.7)

912 (25.9)

77 (24.4)

23 (24.2)

 

 Missing

371 (9.4)

323 (9.2)

30 (9.5)

18 (18.9)

 

Oral glucose tolerance test (OGTT) during pregnancy

3,079 (78.3)

2,772 (78.8)

227 (71.8)

80 (84.2)

0.006

Fasting glucose value, mmol/l

4.9 (0.5)

4.9 (0.4)

5.0 (0.8)

4.9 (0.4)

0.478

 Missing value in OGTT or OGTT not done

885 (22.5)

786 (22.3)

80 (25.3)

19 (20.0)

 

OGTT, 1 h value, mmol/l

7.5 (1.7)

7.5 (1.7)

7.5 (1.7)

7.6 (1.7)

0.895

 Missing value in OGTT or OGTT not done

934 (23.8)

827 (23.5)

87 (27.5)

20 (21.1)

 

OGTT, 2 h value, mmol/l

6.4 (1.4)

6.4 (1.4)

6.4 (1.3)

6.4 (1.2)

0.898

 Missing value in OGTT or OGTT not done

924 (23.5)

820 (23.3)

84 (26.6)

20 (21.1)

 

Gestational diabetes a

786 (19.8)

715 (20.3)

50 (15.8)

21 (22.1)

0.141

Total

3,931 (100)

3,520 (100)

316 (100)

95 (100)

 
  1. Values are N (%) or mean (SD)
  2. aDiagnostic thresholds for gestational diabetes in Finland are 5.3 mmol/l for the fasting stage, 10.0 mmol/l for 1 h or 8.6 mmol/l for 2 h after ingesting the glucose solution
  3. P- values are estimated with Pearson's Chi-squared test (between groups) or One-Way ANOVA (continuous variables)